Las Vegas, NV, June 20, 2013 -- Cytta Corp. (OTCQB: CYCA) is pleased to announce that Medi-Home Individualized Monitoring Systems, Corp. (MHIMS), has become Cytta's national medical implementation and installation partner. MHIMS will be responsible for creating comprehensive remote monitoring solutions, utilizing the revolutionary Cytta ConnectTM telemonitoring system and FDA approved devices, for Insurers, Payors Health Plans, Managed Care Organizations, Health Delivery Organizations, Medical Groups, IPAs, ACO's and Hospitals.
MHIMS has commenced offering this innovative and customizable product mix and services to the marketplace, and has already made numerous well received product demonstrations to some of the largest Healthcare Providers in the Western US for to their population requiring chronic care and remote monitoring. These presentations in California, Arizona and Nevada have resulted in detailed implementation discussions, which are the prelude to formal Cytta ConnectTM installation agreements.
MHIMS has assembled a world class team of medical professionals, who through their experience with the Cytta ConnectTM technology have become experts in the design and implementation of remote medical monitoring system for chronic care. The MHIMS clinical staff is composed of a Medical Director, Nurses and support staff that has developed successful strategies, guidelines and protocols for managing the highest risk individuals as documented in the Whitepaper "Biometric Remote Telemonitoring; to produce a healthy return on investment, decrease resource utilization, and improve care coordination." (cytta.com/whitepapers.php).
Tiffany A. Harz, President of MHIMS states, "We have implemented and installed the most rigorous readmission prevention strategy possible for a large Southern California Medical Group. These patients were at risk for multiple emergency room visits and hospitalizations, and for exacerbations of diseases that could have been avoided if there had been 'in the moment' real time monitoring of these individuals. This model of care has proven to be very effective in significantly reducing costs (over $1,800 per member per month in the above Trial), improving self-management skills, and improving care coordination, while significantly improving Patient and Provider satisfaction".
MHIMS has researched and trained extensively on the Cytta ConnectTM advanced medical monitoring system, during the past year, and has meticulously compiled and developed best practices, protocols, processes and program documentation. These workflow guidelines are designed to be easily customized for any major medical organization's needs.
The Cytta ConnectTM system provides MHIMS and its clients the ability to monitor, track, and trend biometric data 'in the moment' to thousands of these at risk members using off the shelf double FDA approved medical peripherals and an android smartphone running off the Cytta Special Purpose Mobile NetworkTM throughout the United States. The biometric data is instantly sent to the web based Instant EMRTM or Electronic Medical Record and Personal Health Record which is then available on the HIPAA secure servers of our medical clients.
Contact:
Tiffany A. Harz,
President, MHIMS
Office: 714 900 2594
Website: MHIMS.comm
hims.com/contact-us
and
Mr. Gary Campbell,
CEO Cytta Corp
Direct 702 900 7022
Office 702 307 1680
Website: Cytta.com
[email protected]
Investor Relations:
Marmel Communications, LLC
Marlin Molinaro
PH. 1.702.434.8692
Email: [email protected]
About Cytta Corp
Cytta Corp. has developed the Cytta ConnectTM Mobile Health solution. This technology delivers powerful remote health monitoring in an affordable and easy-to-use system. Cytta's cellular Special Purpose NetworkTM and all-wireless medical devices, simplifies the process of gathering important health data. Cytta's dedicated mHealth smartphone combined with Bluetooth medical devices, help patients and their physician's check personal health, wellness and fitness from anywhere, anytime using Cytta's Instant EMRTM. Cytta ConnectTM is the first highly scalable, cellular and WiFi platform for collecting verifiable and objective data for anyone needing medical monitoring; from managing the Chronically Ill to Hospital Readmission prevention, to general health and wellness and for analyzing the data using the Cytta Health EngineTM
Safe Harbor Statement
Forward-Looking Statements
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks detailed in the Company's Form 10-K for the year ended September 30, 2012, and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward looking statements, whether as a result of future events, new information, or otherwise.
SOURCE Cytta Corp.